Former Key Functions:

• Founder & CEO at Bluereg Group & Pharmablue
• Head of EU Regulatory Affairs at Allergan
• Senior regulatory positions at Roche and GSK

Experience : 35+ years

Therapeutic Area: Rare diseases, Neurology, Ophthalmology, Infectious diseases

Leadership Excellence and Entrepreneurial Achievement.
Visionary founder and driving force behind AzurBio Pharma.
Previously, Corinne founded and successfully managed for over a decade Bluereg Group (a leading pharmaceutical consultancy in Europe and the US) and Pharmablue (an Exploitant Service company), both known for their exceptional service quality, before deciding to entrust the keys to a larger consultancy group.

Former Key Functions: 

• VP General Manager at Alnylam
•  Rare Diseases Head at Shire
• VP General Manager France & Benelux at Cubist

Successfully initiated & developed EU organizations from the ground up for three US biotech over a decade, with impactful contributions at HQ/EU Leadership Teams (Alnylam, Forest Laboratories, Cubist)

Experience : 25+ years

Therapeutic Area: Rare diseases, infectious diseases, Immunology, Allergology

Esteemed biotech leader with significant VP roles, driving sector innovations and market expansion, particularly in the EU and US. 
Expert in establishing EU operations for US firms, adept in M&A and business development, currently shaping biotech's future as a key influencer through venture partner, board member, and advisor roles.

Former Key Functions: 

• Managing Director of GHL Conseil
• Key leadership positions at Pfizer and Shire 

Developing and implementing effective marketing and sales strategies across a diverse range of therapeutic areas, in France and Europe.  

Experience: 30+ years

Therapeutic Areas: Cardiology, Immunology & Inflammation, Neurology, Oncology, Rare Diseases 

Multiple influential healthcare consulting roles, shaping transformative strategies and assessing and enhancing access and success in French and EU markets. Demonstrated expertise in innovative consulting methods and deep understanding of healthcare sector dynamics, thanks to 15 years in consulting positions, 16 years in leadership and operational positions in the pharmaceutical industry, and 3 years in fundamental research. 

Former Key Functions:

• SVP Head of Global Regulatory Affairs at Ipsen
• VP EU & international Global Regulatory Affairs at Roche
• VP EU Regulatory Affairs at Wyeth
• Global Head Oncology Drug Regulatory Affairs at Aventis

Experience: 35+ years

Therapeutic Area: Rare diseases, Oncology, Infectious diseases, Vaccines

Expert and seasoned in global regulatory affairs with extensive experience in steering global reg. affairs, patient safety, and R&D quality. Expert in submissions, registrations, and maintenance of pharmaceuticals in the EU, the US, and RoW, and adept at transforming organizations for enhanced cross-functional collaboration.

Former Key Functions :

• Business Development Director positions at Biopharma Excellence and Bluereg Group & Pharmablue
• Licensing Project Manager and Research Team Leader at Galderma

Experience: 20+ years

Therapeutic Area : Dermatology, Immunology, Oncology

Experienced BD Director in international pharmaceutical consultancies, primarily supporting US biotech entering the EU market with a first product; prioritizing long-term, trusted business relationships and service excellence. Proficient in-licensing leadership, fostering alliances to accelerate business expansion. Seasoned immunologist with extensive industry expertise.